SERPLULIMAB

UNII:	S3GQZ2K36V
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	SERPLULIMAB
GSRS Full Record:	S3GQZ2K36V i

2231029-82-4
HLX-10
HLX10
Immunoglobulin G4 [228-proline], anti-(human programmed cell death protein 1) (human-Mus musculus monoclonal HLX10 γ4-chain), disulfide with human-Mus musculus monoclonal HLX10 κ-chain, dimer
Immunoglobulin G4-kappa, anti-[Homo sapiens PDCD1 (programmed cell death 1, PD-1, PD1, CD279)], humanized monoclonal antibody; gamma4 heavy chain Homo sapiens (1-443) [VH (Homo sapiens IGHV3-11*01 (93.8%) -(IGHD) - IGHJ1*01 (90.9%)) [8.8.9] (1-116) -Homo sapiens IGHG4*01 (CH1 (117-214), hinge 1-12 S10>P (224) (215-226), CH2 (227-336), CH3 (337-441), CHS (442-443)) (117-443)], (130-214')-disulfide with kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-39*01 (83.2%) -IGKJ4*01 (90.9%)) [6.3.9] (1'-107') -Homo sapiens IGKC*01 (100%),Km3 A45.1 (153), V101 (191) (108'-214')]; dimer (222-222'':225-225'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa
SERPLULIMAB [USAN]
Serplulimab
Serplulimab [WHO-DD]
serplulimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SERPLULIMAB

Synonyms and Mappings

Resources